Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 57.67%3.76B | 67.64%1.57B | 53.62%2.38B | 151.58%934.6M | 71.32%1.55B | --371.49M | 94.05%905.68M | --466.72M |
| Operating income | 57.67%3.76B | 67.64%1.57B | 53.62%2.38B | 151.58%934.6M | 71.32%1.55B | 371.49M | 94.05%905.68M | 466.72M |
| Cost of sales | -145.77%-1.33B | -177.13%-542.78M | -18.57%-542.2M | -35.19%-195.86M | -64.52%-457.3M | ---144.88M | -104.79%-277.96M | ---135.73M |
| Operating expenses | -145.77%-1.33B | -177.13%-542.78M | -18.57%-542.2M | -35.19%-195.86M | -64.52%-457.3M | -144.88M | -104.79%-277.96M | -135.73M |
| Gross profit | 31.73%2.43B | 38.61%1.02B | 68.27%1.84B | 225.99%738.74M | 74.33%1.09B | 226.61M | 89.65%627.71M | 330.99M |
| Selling expenses | -54.18%-631.92M | -37.14%-272.11M | -25.24%-409.85M | -39.02%-198.42M | -9.63%-327.25M | ---142.73M | -41.21%-298.5M | ---211.39M |
| Administrative expenses | -13.86%-725.96M | -26.33%-307.16M | -43.81%-637.62M | -13.09%-243.14M | -18.58%-443.37M | ---215M | -17.21%-373.91M | ---319M |
| Research and development expenses | -63.30%-5.15B | -62.01%-2.3B | -33.38%-3.16B | -35.34%-1.42B | -25.87%-2.37B | ---1.05B | -64.38%-1.88B | ---1.14B |
| Impairment and provision | 81.32%-9.58M | 72.26%-14.77M | -146.47%-51.25M | -643.12%-53.24M | -59.47%-20.79M | ---7.16M | -155.77%-13.04M | ---5.1M |
| -Other impairment is provision | 81.32%-9.58M | 72.26%-14.77M | -146.47%-51.25M | -643.12%-53.24M | -59.47%-20.79M | ---7.16M | -155.77%-13.04M | ---5.1M |
| Special items of operating profit | 181.12%756.7M | 295.38%277.96M | 719.89%269.18M | 240.47%70.3M | 116.89%32.83M | ---50.05M | -1,617.04%-194.39M | --12.81M |
| Operating profit | -55.71%-3.34B | -44.03%-1.59B | -5.60%-2.14B | 10.66%-1.11B | 4.76%-2.03B | -1.24B | -59.66%-2.13B | -1.34B |
| Financing income | 5.40%403.94M | -18.98%173.83M | 128.83%383.23M | 145.85%214.55M | 60.22%167.47M | --87.27M | 270.15%104.53M | --28.24M |
| Financing cost | -90.06%-14.09M | 2.14%-3.71M | 14.31%-7.41M | 17.36%-3.79M | -14.61%-8.65M | ---4.59M | 54.51%-7.55M | ---16.59M |
| Special items of earning before tax | -282.48%-7.52B | 9.24%-3.81B | 184.55%4.12B | -474.28%-4.19B | 27.16%-4.87B | ---730.37M | -772.74%-6.69B | ---766.51M |
| Earning before tax | -545.17%-10.47B | -2.75%-5.23B | 134.86%2.35B | -169.97%-5.09B | 22.70%-6.74B | -1.89B | -317.41%-8.72B | -2.09B |
| Tax | 26.36%-3.32M | 54.36%-4.15M | -188.81%-4.51M | -160.49%-9.09M | 18.77%5.08M | ---3.49M | -83.97%4.27M | --26.65M |
| After-tax profit from continuing operations | -546.17%-10.47B | -2.65%-5.23B | 134.82%2.35B | -169.96%-5.1B | 22.72%-6.74B | -1.89B | -322.59%-8.72B | -2.06B |
| Earning after tax | -546.17%-10.47B | -2.65%-5.23B | 134.82%2.35B | -169.96%-5.1B | 22.72%-6.74B | -1.89B | -322.59%-8.72B | -2.06B |
| Minority profit | -391.67%-354K | -488.24%-100K | -125.00%-72K | -6.25%-17K | 96.86%-32K | ---16K | 54.90%-1.02M | ---2.26M |
| Profit attributable to shareholders | -546.14%-10.47B | -2.64%-5.23B | 134.82%2.35B | -169.96%-5.1B | 22.71%-6.74B | -1.89B | -323.01%-8.72B | -2.06B |
| Basic earnings per share | -258.82%-0.81 | 76.80%-0.42 | 120.40%0.51 | -154.93%-1.81 | 25.37%-2.5 | -0.71 | -313.58%-3.35 | -0.81 |
| Diluted earnings per share | -376.47%-0.81 | 76.80%-0.42 | 93.20%-0.17 | -154.93%-1.81 | 25.37%-2.5 | -0.71 | -313.58%-3.35 | -0.81 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | -- | PwC | -- | PwC | -- | PwC | PwC |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.